David E. Anderson
2018
In 2018, David E. Anderson earned a total compensation of $921.9K as Chief Scientific Officer at VBI Vaccines, a 77% increase compared to previous year.
Compensation breakdown
| Bonus | $126,640 |
|---|---|
| Option Awards | $419,000 |
| Salary | $330,000 |
| Stock Awards | $41,750 |
| Other | $4,500 |
| Total | $921,890 |
Anderson received $419K in option awards, accounting for 45% of the total pay in 2018.
Anderson also received $126.6K in bonus, $330K in salary, $41.8K in stock awards and $4.5K in other compensation.
Rankings
In 2018, David E. Anderson's compensation ranked 9,589th out of 14,244 executives tracked by ExecPay. In other words, Anderson earned more than 32.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,589 out of 14,244 | 33rd |
Division Manufacturing | 3,854 out of 5,759 | 33rd |
Major group Chemicals And Allied Products | 1,451 out of 2,122 | 32nd |
Industry group Drugs | 1,221 out of 1,811 | 33rd |
Industry Pharmaceutical Preparations | 941 out of 1,385 | 32nd |
Source: SEC filing on April 29, 2019.
Anderson's colleagues
We found two more compensation records of executives who worked with David E. Anderson at VBI Vaccines in 2018.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019